Results 31 to 40 of about 5,568 (155)

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia [PDF]

, 2006
Background Gemtuzumab ozogamicin (GO) is a cytotoxic anti-CD33 monoclonal antibody that has given promising preliminary results in adult myeloid CD33+ AML.
Benoit Brethon, Anne Auvrignon, Claire Galambrun, Karima Yakouben, Thierry Leblanc, Yves Bertrand, Guy Leverger, André Baruchel, S Amadori, C Behar, WG Woods, RF Stevens, U Creutzig, Y Perel, B Vidarsson, VM Santana, VM Santana, U Creutzig, RG Andrews, EL Sievers, EL Sievers, PR Hamann, LM Hinman, PF Bross, LH Leopold, P Rajvanshi, FJ Giles, AD Cohen, M Wadleigh, EL Sievers, CM Zwaan, D Reinhardt, RJ Arceci, AJ McCarthy, G Fleischhack, DKH Webb, RA Larson, WJ Kell   +37 more
core   +2 more sources

International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean

Globalization and Health, 2020
Background Cooperation in public health and in oncology in particular, is currently a major issue for the island of Martinique, given its geopolitical position in the Caribbean region.
Clarisse Joachim, Thierry Almont, Moustapha Drame, Cédric Contaret, Mylène Vestris, Fatiha Najioullah, Aude Aline-Fardin, Patrick Escarmant, Nicolas Leduc, Nathalie Grossat, Xavier Promeyrat, Stefanos Bougas, Eva Papadopoulou, Vincent Vinh-Hung, Emmanuelle Sylvestre, Jacqueline Veronique-Baudin   +15 more
doaj   +1 more source

Pour un modèle de prévision de la main-d’oeuvre médicale au Québec [PDF]

, 1982
Planifier la main-d’oeuvre consiste essentiellement à chercher à harmoniser les effectifs nécessaires et les effectifs disponibles. Dans ce texte, l’auteur, s’intéressant aux effectifs disponibles, expose les principaux éléments d’un modelé
La Haye, Jacques
core   +1 more source

Effet hématotoxique de la consommation d'argile géophagique contaminée par des métaux lourds : étude expérimentale chez des rats Wistar (Rattus norvegicus)

Revue des Sciences de la Santé
La géophagie, c’est-à-dire l’ingestion volontaire de sols argileux, est largement pratiquée en Afrique subsaharienne, surtout chez les femmes enceintes. Cependant, ses effets toxicologiques restent peu documentés.
Lionel S. ASAMBOA, Nelly K. NSIMBA, Esther M. MPIANA, Dorcas T. SOLA, Sarah B. KINSONA, Claudia M. MBANDA, Jean-Jacques D. AMOGU, Max V. SEKE, Gisèle K. MAKENGO, Joel K. TUAKUILA, Odette N. KABENA   +10 more
doaj   +1 more source

Development of a potency assay for CD34+ cell-based therapy

Scientific Reports, 2023
We have previously shown that intracardiac delivery of autologous CD34+ cells after acute myocardial infarction (AMI) is safe and leads to long term improvement. We are now conducting a multicenter, randomized, controlled Phase I/IIb study in post-AMI to
Anne Aries, Christine Vignon, Céline Zanetti, Aurélien Goubaud, Arthur Cormier, Anne Diederichs, Rachid Lahlil, Philippe Hénon, Ibon Garitaonandia   +8 more
doaj   +1 more source

Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs) [PDF]

, 2018
BACKGROUND: Although patients with advanced or metastatic lung cancer have poor prognosis, admission to the ICU for management of life-threatening complications has increased over the years.
A Steven, A-C Barbot, A-C Toffart, AK Adam, C Hamard, CA Reichner, CG Slatore, DV Schapira, E Azoulay, E Azoulay, E Biskup, F Vincent, FS Taccone, JI Salluh, JL Vincent, JR Gall Le, K Puxty, M Früh, M Garrouste-Orgeas, M Maltoni, M Soares, M Soares, M Soares, ME Charlson, MM Oken, MR Bonomi, P Zarogoulidis, R Fisher, RR Jennens, S Anisoglou, S Roques, T Cooksley, T Tanvetyanon, X Nan, Y Zerbib, Y-F Chen, YJ Kim   +36 more
core   +2 more sources

Prise en charge des syndromes myélodysplasiques au Maroc à propos d'une étude mono-centrique

The Pan African Medical Journal, 2020
Il s´agit d´une étude rétrospective de type descriptive et analytique, réalisée au sein du service de l´hématologie clinique de l´hôpital militaire d´instruction Mohammed V de Rabat, étalée sur 10 ans et portant sur 76 patients dont le diagnostique de ...
Hicham El Maaroufi, Mounir Ababou, Adnane Hammani, Siham Ahchouch, Salim Jennane, Mehdi Mahtat, Mohamed Mikdmae, Nezha Messaoudi, Kamal Doghmi   +8 more
doaj   +1 more source

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network

Haematologica, 2015
The purpose of our study is to determine the outcome of patients with systemic non-Hodgkin lymphoma presenting with neurologic localization at diagnosis, as well as the impact of consolidation in terms of high-dose therapy followed by autologous stem ...
Gandhi Damaj, Sarah Ivanoff, Diane Coso, Loïc Ysaebert, Sylvain Choquet, Caroline Houillier, Anne Parcelier, Wajed Abarah, Zora Marjanovic, Rémy Gressin, Reda Garidi, Momar Diouf, Anne-Claire Gac, Jehan Dupuis, Xavier Troussard, Franck Morschhauseur, Hervé Ghesquières, Carole Soussain   +17 more
doaj   +1 more source

Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. [PDF]

, 2012
L'article final de l'éditeur contient 9 pages. Le manuscrit accepté contient 32 pages.International audienceMutations of the TMPRSS6 gene, which encodes Matriptase-2, are responsible for iron-refractory iron-deficiency anemia.
Aguilar-Martinez, Patricia, Beaumont, Carole, Donadieu, Jean, Grandchamp, Bernard, Guillem, Flavia, Isidor, Bertrand, Kannengiesser, Caroline, Lenoir, Anne, Matak, Pavle, Méchinaud, Françoise, Nicolas, Gaël, Oudin, Claire, Vaulont, Sophie   +12 more
core   +3 more sources

International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani, Sofia Lejon Crottet, Sophie Waldvogel, Charlotte Engström, Serelina Coluzzi, Antonella Matteocci, Janis R. Hamilton, Levent Tufan Kumas, Karen M. K. de Vooght, Jill R. Storry, Jennylyn Flores, Núria Nogués, Carlos Cotorruelo, Molly Rutherford, Eveline B. Nilsen, Monika Pelc‐Kłopotowska, Jolanta Korzeniowska, Alessandra Baffa, Inna Sareneva, Nor Hafizah Ahmad, Katarzyna Szczudlo, Athif Rahman, Laser Sanal, Lise Jørgensen, Karolina Majewska Rochowiak, Monika Salwierz, Elisaveta Grancharova, Bojana Zivkovic, Jessica Alvarez, Mareike Riedl, Achim Knappik   +30 more
wiley   +1 more source